1P-LSD Molecule Blotter Tabs (100 µg) are laboratory-grade Lysergamide blotters developed for scientific, analytical, and educational research. Each tab is precisely infused with 100 micrograms of 1-Propionyl-Lysergic Acid Diethylamide (1P-LSD) a well-studied analogue of LSD-25, known for its near-identical receptor activity and consistent behavior in laboratory conditions.
These blotters are designed for accurate measurement, superior purity, and reliable performance in neurochemical, pharmacological, and comparative receptor studies. The molecule artwork on each blotter reflects its scientific origin and reinforces its professional use within research environments.
1P-LSD is a prodrug of LSD-25, meaning it converts to LSD once metabolized, allowing researchers to study its interaction with serotonin (5-HT2A) receptors. It provides stable results suitable for chromatography, spectroscopy, or chemical mapping analyses.
Content:
100 µg of 1P-LSD per tab
Molecular Formula: C23H29N3O2
High-absorbency food-safe blotter paper
Labeled “For Research Use Only – Not for Human Consumption”
Benefits (For Research Use):
Accurate 100 µg dose for reproducible research outcomes
Chemically stable for extended storage
Consistent concentration across blotter sheets
Ideal for analytical and neurochemical testing environments
Usage:
Handle with gloves and precision instruments in a controlled laboratory. Suitable for chemical analysis, chromatography testing, and receptor mapping. Avoid moisture or exposure to direct light, as lysergamides are light-sensitive.
Side Effects (Research Notes):
In studies comparing 1P-LSD with LSD-25, similar physiological and neurological responses were observed, such as increased serotonin binding, altered sensory data, and heightened cognitive processing. These are observational laboratory results not intended for in vivo human trials.
Storage:
Store sealed in an airtight, light-resistant container, ideally refrigerated (2–8°C) to maintain purity and potency.





















There are no reviews yet.